Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Lupus anticoagulant refers to autoantibodies that interfere with blood clotting tests in the laboratory. Despite their name suggesting they prevent clotting, these antibodies are actually associated with an increased risk of blood clots. Blood tests are essential for detecting the presence of these antibodies.
This test measures how long it takes blood to clot through two different pathways. Lupus anticoagulants are autoantibodies that interfere with phospholipid-dependent clotting reactions, causing prolonged clotting times, particularly in the PTT portion of the test. An unexpectedly prolonged PTT that doesn't correct with mixing studies often indicates the presence of lupus anticoagulant.
Lupus anticoagulants are antibodies that target phospholipid-binding proteins in cell membranes. Their detection requires specialized blood testing that measures how these antibodies affect normal clotting pathways. The presence of lupus anticoagulant is often suspected when routine clotting tests show unexpectedly prolonged results.
When lupus anticoagulant is present, the PTT is typically prolonged because these antibodies interfere with the phospholipids used in the laboratory test. Paradoxically, while these antibodies prolong clotting times in laboratory tests, they are associated with an increased risk of thrombosis (blood clots) in the body. Additional confirmatory tests may be needed to definitively diagnose lupus anticoagulant syndrome.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment.